Core Insights - Tigermed has completed the acquisition of Micron, a Japan-based Contract Research Organization (CRO) specializing in medical imaging and clinical trial services [1][4] - Micron, founded in 2005, has over 160 employees and has supported the successful approval of over 40 drugs, establishing itself as a leader in imaging biomarkers and AI-powered imaging support [2][3] - The integration of Micron into Tigermed's global network is expected to enhance Tigermed's capabilities in medical imaging across Japan and the Asia-Pacific region [4][5] Company Overview - Tigermed is a leading global provider of integrated research and development solutions for the biopharmaceutical and medical device industry, collaborating with over 3,600 customers and operating in more than 180 locations worldwide [7] - Micron provides a range of clinical development services centered around medical imaging, including monitoring, quality control, and centralized imaging review, and supports foreign medtech and biotech companies conducting clinical trials in Japan [6] Strategic Implications - The acquisition is anticipated to leverage Micron's expertise and technology to enhance Tigermed's competitiveness in medical imaging and clinical services, contributing to global medical research and development [5][4] - Micron's established reputation and experience in the medical imaging sector will provide Tigermed with a stronger platform for expansion and innovation in the healthcare industry [5][3]